5-HTTLPR genotype and gender, but not chronic fluoxetine administration, are associated with cortical TREK1 protein expression in rhesus macaques

被引:6
作者
Bogdan, R. [1 ,2 ,3 ]
Fitzgibbon, H. [2 ]
Woolverton, W. L. [2 ]
Bethea, C. L. [4 ]
Iyo, A. H. [2 ]
Stockmeier, C. A. [2 ]
Kyle, P. B. [5 ]
Austin, M. C. [2 ]
机构
[1] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA
[2] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, University, MS 38677 USA
[3] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA
[4] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA
[5] Univ Mississippi, Med Ctr, Dept Pathol, University, MS 38677 USA
关键词
TREK1; Serotonin; SSRI; Rhesus macaques; Monkey; 5-HTTLPR; Depression; Western blot; DEPRESSION-RESISTANT PHENOTYPE; TRANSPORTER GENE VARIATION; POTASSIUM CHANNEL; MAJOR DEPRESSION; SEROTONIN; RESPONSES; ABUSE;
D O I
10.1016/j.neulet.2011.08.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
TREK1 is a widely expressed background potassium channel. Similar to mice treated with selective serotonin reuptake inhibitors (SSRIs), TREK1 knockout mice are resistant to depression-like behavior and have elevated serotonin levels leading to speculation that TREK1 inhibition may contribute to the therapeutic effects of SSRIs. This study examined how chronic fluoxetine administration and a common functional polymorphism in the serotonin-transporter-linked promoter region (5-HTTLPR) influence cortical TREK1 expression in 24 rhesus monkeys. The short rh5-HTTLPR allele as well as female gender were associated with reduced cortical TREK1 protein expression but chronic SSRI administration had no effect. These results suggest that serotonin may influence TREK1, but that chronic SSRI treatment does not result in long lasting changes in cortical TREK1 protein expression. TREK1 gender differences may be related to gender differences in serotonin and require further research. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:83 / 86
页数:4
相关论文
共 20 条
[11]   Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment [J].
Liou, Ying-Jay ;
Chen, Tai-Jui ;
Tsai, Shih-Jen ;
Yu, Younger W-Y ;
Cheng, Chih-Ya ;
Hong, Chen-Jee .
PHARMACOGENETICS AND GENOMICS, 2009, 19 (10) :735-741
[12]   Spadin, a Sortilin-Derived Peptide, Targeting Rodent TREK-1 Channels: A New Concept in the Antidepressant Drug Design [J].
Mazella, Jean ;
Petrault, Olivier ;
Lucas, Guillaume ;
Deval, Emmanuel ;
Beraud-Dufour, Sophie ;
Gandin, Carine ;
El-Yacoubi, Malika ;
Widmann, Catherine ;
Guyon, Alice ;
Chevet, Eric ;
Taouji, Said ;
Conductier, Gregory ;
Corinus, Alain ;
Coppola, Thierry ;
Gobbi, Gabriella ;
Nahon, Jean-Louis ;
Heurteaux, Catherine ;
Borsotto, Marc .
PLOS BIOLOGY, 2010, 8 (04)
[13]   Serotonin transporter gene variation, infant abuse, and responsiveness to stress in rhesus macaque mothers and infants [J].
McCormack, K. ;
Newman, T. K. ;
Higley, J. D. ;
Maestripieri, D. ;
Sanchez, M. M. .
HORMONES AND BEHAVIOR, 2009, 55 (04) :538-547
[14]   Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: Association of TREK1 and treatment resistance in the STAR*D study [J].
Perlis, Roy H. ;
Moorjani, Priya ;
Fagerness, Jesen ;
Purcell, Shaun ;
Trivedi, Madhukar H. ;
Fava, Maurizio ;
Rush, A. John ;
Smoller, Jordan W. .
NEUROPSYCHOPHARMACOLOGY, 2008, 33 (12) :2810-2819
[15]   Effects of sex and early maternal abuse on adrenocorticotropin hormone and cortisol responses to the corticotropin-releasing hormone challenge during the first 3 years of life in group-living rhesus monkeys [J].
Sanchez, Mar M. ;
McCormack, Kai ;
Grand, Alison P. ;
Fulks, Richelle ;
Graff, Anne ;
Maestripieri, Dario .
DEVELOPMENT AND PSYCHOPATHOLOGY, 2010, 22 (01) :45-53
[16]   Optical probing of a dynamic membrane interaction that regulates the TREK1 channel [J].
Sandoz, Guillaume ;
Bell, Sarah C. ;
Isacoff, Ehud Y. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (06) :2605-2610
[17]   Decreased expression of Freud-1/CC2D1A, a transcriptional repressor of the 5-HT1A receptor, in the prefrontal cortex of subjects with major depression [J].
Szewczyk, Bernadeta ;
Albert, Paul R. ;
Rogaeva, Anastasia ;
Fitzgibbon, Heidi ;
May, Warren L. ;
Rajkowska, Grazyna ;
Miguel-Hidalgo, Jose J. ;
Stockmeier, Craig A. ;
Woolverton, William L. ;
Kyle, Patrick B. ;
Wang, Zhixia ;
Austin, Mark C. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (08) :1089-1101
[19]   Fluoxetine pharmacokinetics in pediatric patients [J].
Wilens, TE ;
Cohen, L ;
Biederman, J ;
Abrams, A ;
Neft, D ;
Faird, N ;
Sinha, V .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (06) :568-575
[20]   Fluoxetine attenuates the inhibitory effect of glucocorticoid hormones on neurogenesis in vitro via a two-pore domain potassium channel, TREK-1 [J].
Xi, Guangjun ;
Zhang, Xiangrong ;
Zhang, Ling ;
Sui, Yuxiu ;
Hui, Jiaojie ;
Liu, Shanshan ;
Wang, Yingxin ;
Li, Lingjiang ;
Zhang, Zhijun .
PSYCHOPHARMACOLOGY, 2011, 214 (03) :747-759